Scioderm, Inc. Closes $20 Million Series B Round of Financing

Funds will be used to complete the clinical development program for ZorblisaTM DURHAM, N.C., Dec. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Scioderm, Inc., today announced it raised $20 million in a Series B financing round led by Redmile G... Biopharmaceuticals, Dermatology, Venture CapitalScioderm, Zorblisa, Epidermolysis Bullosa
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news